Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Medical Genetics|January 26, 2012
Data mining of high density genomic variant data for prediction of Alzheimer's disease riskNatalia Briones, Valentin Dinu
Radiation Research|March 23, 2017
Developing Human Radiation Biodosimetry Models: Testing Cross-Species Conversion Approaches Using an Ex Vivo Model SystemJin G Park, Sunirmal Paul, Natalia Briones, et al.
Cancers|October 18, 2019
PD-1-Associated Gene Expression Signature of Neoadjuvant Trastuzumab-Treated Tumors Correlates with Patient Survival in HER2-Positive Breast CancerWilliam P D Hendricks, Natalia Briones, Rebecca F Halperin, et al.
Genes|November 10, 2020
Identification of Genetic Susceptibility Factors Associated with Canine Gastric Dilatation-VolvulusIgnazio S Piras, Nieves Perdigones, Victoria Zismann, et al.
Veterinary and Comparative Oncology|March 31, 2026
Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene FusionsSharadha Sakthikumar, William P D Hendricks, David Rainford, et al.
Nature Methods|June 18, 2013
Genome-wide profiling of human cap-independent translation-enhancing elementsBrian P Wellensiek, Andrew C Larsen, Bret Stephens, et al.
Scientific Reports|February 8, 2025
Characterization of the genomic landscape of canine diffuse large B-cell lymphoma reveals recurrent H3K27M mutations linked to progression-free survivalAnna Darlene van der Heiden, Raphaela Pensch, Sophie Agger, et al.
Plos One|July 22, 2022
Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patientsShukmei Wong, E J Ehrhart, Samuel Stewart, et al.
Gynecologic Oncology|December 17, 2020
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell linesAnthony N Karnezis, Shary Yuting Chen, Christine Chow, et al.
Biomarker Research|July 25, 2023
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxelJessica D Lang, Tuong Vi V Nguyen, Maren K Levin, et al.
Pageof 2